Vi­o­let Ther­a­peu­tics snags $10.6M in seed fund­ing for plat­forms that go be­yond sin­gle-cell se­quenc­ing

Pre­clin­i­cal biotech Vi­o­let Ther­a­peu­tics emerged from stealth Wednes­day with a $10.6 mil­lion seed round for its plat­forms that go be­yond sin­gle-cell se­quenc­ing (al­low­ing re­searchers to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER